Why Are Ozone Catalysts Suitable for Pharmaceutical Wastewater Pretreatment?

Due to its high concentrations of refractory organic compounds and residual antibiotics, pharmaceutical wastewater exhibits low efficiency when subjected to direct biochemical treatment, and the treatment system is prone to collapse. Catalytic ozonation technology is capable of efficiently generating hydroxyl radicals under ambient temperatures and near-neutral pH conditions; it degrades pollutants non-selectively and significantly enhances the biodegradability of the wastewater. This technology has already been successfully implemented in engineering applications across numerous pharmaceutical production bases within China. This article analyzes the mechanistic basis for this technology’s suitability as well as its comprehensive advantages.

pemangkin penguraian ozon

I. Sources and Treatment Challenges of Pharmaceutical Wastewater
Pharmaceutical wastewater primarily originates from the production of active pharmaceutical ingredients (APIs), specifically from fermentation filtrates, extraction residues, distillation bottoms, and equipment cleaning water. The water quality varies significantly across different types of wastewater: wastewater from antibiotic production typically exhibits a Chemical Oxygen Demand (COD) ranging from 5,000 to 20,000 mg/L and suspended solids ranging from 5,000 to 23,000 mg/L; wastewater from chemical synthesis pharmaceuticals contains toxic substances such as nitro compounds, anilines, and heavy metals; and wastewater from traditional Chinese medicine (TCM) production is rich in refractory natural organic compounds, including tannins, lignins, and alkaloids.

Even at concentrations as low as the microgram-per-liter level, residual antibiotics can inhibit microbial metabolic activity, leading to the collapse of biochemical treatment systems. Furthermore, substances such as chlorinated organics and polycyclic aromatic hydrocarbons (PAHs) possess “three-carcinogenic” effects (carcinogenic, mutagenic, and teratogenic) and persist in water bodies for extended periods. Consequently, effective pretreatment is imperative prior to biochemical processing to eliminate biological toxicity and enhance biodegradability.

II. The Core Mechanism of Ozone Catalysts
Ozone catalysts utilize transition metal oxides (such as manganese, copper, and iron) as active components, which are supported on high-specific-surface-area carriers such as alumina or ceramics. As the ozone stream flows through the catalyst bed, active sites on the catalyst surface adsorb and activate the ozone molecules, thereby facilitating their cleavage to generate hydroxyl radicals (·OH).

With an oxidation potential reaching as high as 2.80 V, hydroxyl radicals react non-selectively and rapidly with the vast majority of organic pollutants. They cleave saturated bonds and open aromatic ring structures, breaking down large organic molecules into smaller intermediate products, which are then further mineralized. The catalyst itself is not consumed during the process; it operates efficiently under neutral pH conditions (5–8), requires no chemical additives, and prevents secondary pollution.

III. Why It Is Particularly Suitable for Pharmaceutical Wastewater Pretreatment
1. Rapid Elimination of Antibiotic Bacteriostatic Activity
Hydroxyl radicals rapidly attack the active functional groups of antibiotics (such as the β-lactam ring and tetracycline skeleton), causing ring-opening and bond cleavage, thereby completely eliminating their bacteriostatic capabilities. Studies have shown that when a manganese-based catalyst is used to treat simulated wastewater containing oxytetracycline, the antibiotic removal rate exceeds 96% within 30 minutes; furthermore, the resulting degradation products no longer inhibit subsequent biochemical treatment systems.

2. Efficient Degradation of Recalcitrant Organic Pollutants
Aromatic and heterocyclic compounds often exhibit resistance to conventional ozonation, resulting in ozone utilization rates of typically less than 50%. The catalyst shifts the reaction mechanism toward a radical-dominated, non-selective oxidation process, thereby accelerating the degradation rate by several-fold to several-tens-fold. For instance, when a chemically synthesized pharmaceutical wastewater (with a COD of approximately 8,000 mg/L) underwent catalytic oxidation, the COD removal rate reached 45%–55%, whereas conventional ozonation alone achieved less than 20%.

3. Significant Improvement in Biodegradability
Large, recalcitrant organic molecules are broken down into smaller molecular substances—such as organic acids, aldehydes, and alcohols—causing the B/C ratio (BOD/COD) to rise from an initial range of 0.1–0.2 to 0.3–0.5 or higher, with some cases reaching as high as 0.6. Consequently, the hydraulic retention time required for subsequent biochemical treatment is reduced by 30%–50%, and aeration energy consumption is lowered by 20%–30%.

4. Adaptability to Fluctuations in Water Quality and Flow Rate
By adjusting the ozone dosage (30–120 mg/L) and retention time (30–120 minutes), the system can flexibly adapt to varying pollutant loads; additionally, the fixed-bed catalyst layer possesses a substantial buffering capacity.

IV. Advantages Over Traditional Pretreatment Technologies
Compared to the Fenton oxidation method—a technique commonly employed in the pretreatment of pharmaceutical wastewater—catalytic ozonation technology demonstrates distinct advantages across multiple aspects. Regarding secondary pollution, Fenton oxidation requires the addition of ferrous sulfate and hydrogen peroxide under strongly acidic conditions. The reaction generates a substantial amount of iron-containing sludge—approximately 1 to 3 kilograms per ton of wastewater—which is classified as hazardous waste and entails high disposal costs. In contrast, catalytic ozonation requires no chemical additives; its solid catalyst is reusable, and the sole reaction byproduct is oxygen. Since the entire process generates no chemical sludge, it fundamentally eliminates the problem of secondary pollution.

In terms of reaction conditions, Fenton oxidation necessitates adjusting the wastewater pH to a strongly acidic range of 2 to 4, followed by the addition of a base after the reaction concludes to restore the pH to a neutral level. This process consumes large quantities of acids and bases and is operationally cumbersome. Catalytic ozonation, however, can operate directly at ambient temperatures and under the near-neutral pH conditions (5–8) typical of raw wastewater, requiring no acid or base adjustments. This approach not only saves on chemical costs but also simplifies the overall process workflow.

Regarding operational management, Fenton oxidation requires manual, periodic preparation and dosing of various chemical reagents—a complex procedure that entails inherent safety risks. Catalytic ozonation systems, conversely, can be highly automated; integrated with a PLC, they enable real-time online water quality monitoring and automatic adjustment of ozone output. The entire process operates autonomously, minimizing the need for on-site personnel and facilitating convenient operational management.

Regarding operating costs—taking a pharmaceutical wastewater treatment facility with a capacity of 500 tons per day as an example—the Fenton process generates approximately 180 tons of iron-containing hazardous waste annually. Hazardous waste disposal fees alone exceed 150,000 RMB; when combined with the costs of acids, bases, and other reagents, the direct operating cost per ton of wastewater amounts to approximately 4.5 RMB. For the catalytic ozonation process, electricity consumption (primarily for the ozone generator) costs approximately 2.8 RMB per ton of wastewater, while the amortized annual cost of catalyst depletion is about 0.4 RMB per ton. With no costs associated with chemical reagents or hazardous waste disposal, the total operating cost per ton of wastewater is approximately 3.2 RMB—nearly 30% lower than that of the Fenton process. Furthermore, high-quality ozone catalysts can remain effective for over two years under reasonable operating conditions; should their activity decline, much of their original efficacy can be restored through offline thermal regeneration, thereby further extending their service life and reducing replacement costs.

In summary, catalytic ozonation demonstrates significant superiority over the traditional Fenton oxidation process in terms of environmental benefits, economic efficiency, and operational convenience.

V. Engineering Practice and Summary
Extensive engineering practice demonstrates that catalytic ozonation, when applied to the pretreatment of pharmaceutical wastewater, can achieve a Chemical Oxygen Demand (COD) removal rate of 40% to 60%. Furthermore, this process requires no pH adjustment and generates no chemical sludge, allowing for prolonged periods of stable system operation. The fundamental rationale for selecting catalytic ozonation for pharmaceutical wastewater pretreatment lies in its ability to simultaneously achieve three key objectives: reducing COD levels, eliminating the antibacterial activity of antibiotics, and significantly enhancing biodegradability—all without generating secondary pollution and while maintaining controllable operating costs. For pharmaceutical enterprises facing regulatory mandates to upgrade their environmental protection standards, catalytic ozonation represents a technically and economically sound pretreatment pathway that has been thoroughly validated through real-world engineering applications.

author：Gloria
date:2026-05-13